3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
14
Leukemia, Myeloid, Acute
12
Myelodysplastic Syndromes
8
Myeloproliferative Disorders
5
Lymphoma, Non-Hodgkin
5
Lymphoma, Mantle-Cell
5
Lymphoma, Follicular
5
Hodgkin Disease
5
Burkitt Lymphoma
5
Multiple Myeloma
4
Lymphoma
4
Leukemia, Myelomonocytic, Chronic
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Leukemia
4
Anemia, Refractory, with Excess of Blasts
4
Waldenstrom Macroglobulinemia
3
Recurrence
3
Primary Myelofibrosis
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Lymphoma, T-Cell, Cutaneous
3
Lymphoma, Large B-Cell, Diffuse
3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Leukemia, Lymphoid
3
Leukemia, Biphenotypic, Acute
3
Hematologic Neoplasms
3
Congenital Abnormalities
3
Blast Crisis
3
Thrombocythemia, Essential
2
Sezary Syndrome
2
Precancerous Conditions
2
Interventions
Vincristine
9
Cyclophosphamide
8
Magnetic Resonance Spectroscopy
7
X-Rays
6
Temozolomide
6
Specimen Handling
6
Phantoms, Imaging
6
Irinotecan
6
Biopsy
5
Radiotherapy
4
Radiation
4
Nuclear Medicine Department, Hospital
4
Dactinomycin
4
fludarabine
3
Vinorelbine
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
larotrectinib
2
ivosidenib
2
ensartinib
2
Proton Therapy
2
LY3023414
2
Ifosfamide
2
Filgrastim
2
Etoposide
2
Doxorubicin
2
Dexrazoxane
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Rhabdomyosarcoma
×
Peripheral Blood Stem Cell Transplantation
×
90 days
×
Clear all
No trials found.